SUSAN SLOAN: Open Payments
NPI 1134508880 · SCIENCE HILL, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$943 in 71 payments from 16 companies in 2025. Trend: 2023 $1,488 · 2024 $1,210 · 2025 $943
Food & beverage: $943
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 18 | $191 |
| Novo Nordisk Inc | 17 | $180 |
| ABBVIE INC. | 11 | $143 |
| Vanda Pharmaceuticals Inc. | 4 | $91 |
| Phathom Pharmaceuticals, Inc. | 4 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| PFIZER INC. | 2 | $34 |
| Amgen Inc. | 2 | $31 |
Products named: REXULTI, FANAPT, Rybelsus, QULIPTA, VRAYLAR, VOQUEZNA, Ozempic, TRINTELLIX.
Industry payments across KY — which companies pay providers there.
